No impact of atrial fibrillation on mortality risk in optimally treated heart failure patients.
about
Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillationRecent trends in the incidence, treatment, and prognosis of patients with heart failure and atrial fibrillation (the Worcester Heart Failure Study).Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.Atrial Fibrillation on Intensive Care Unit Admission Independently Increases the Risk of Weaning Failure in Nonheart Failure Mechanically Ventilated Patients in a Medical Intensive Care Unit: A Retrospective Case-Control StudyAtrial fibrillation in heart failure.
P2860
No impact of atrial fibrillation on mortality risk in optimally treated heart failure patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
No impact of atrial fibrillati ...... reated heart failure patients.
@en
No impact of atrial fibrillati ...... reated heart failure patients.
@nl
type
label
No impact of atrial fibrillati ...... reated heart failure patients.
@en
No impact of atrial fibrillati ...... reated heart failure patients.
@nl
prefLabel
No impact of atrial fibrillati ...... reated heart failure patients.
@en
No impact of atrial fibrillati ...... reated heart failure patients.
@nl
P2093
P2860
P356
P1433
P1476
No impact of atrial fibrillati ...... treated heart failure patients
@en
P2093
Arnljot Tveit
Berit Flonaes
Ellinor Aaser
Gisle Froland
Kari Korneliussen
Morten Grundtvig
P2860
P304
P356
10.1002/CLC.20939
P577
2011-07-27T00:00:00Z